Target intelligence / Profile preview

ANKRD65 antisense RNA 1 (ANKRD65-AS1)

Target: ANKRD65-AS1
Molecular classification: Long non-coding RNA (lncRNA), Antisense RNA

Overview

ANKRD65 antisense RNA 1 (ANKRD65-AS1) is a human long non-coding antisense RNA gene. It is affiliated with the class of lncRNAs and does not encode a protein. Its gene is located on chromosome 1. As with other antisense RNAs, its presumed function is post-transcriptional gene regulation or chromatin modification through cis or trans regulatory effects. However, its specific biological function, disease relevance, or therapeutic targeting has not been reported. No clinical, pharmacological, or biomarker associations are currently established for this gene[4][1][5].

Mechanism of action

Not applicable; no drugs targeting ANKRD65-AS1 are known

Biological functions

Presumed gene expression regulation via antisense mechanisms (general to antisense RNAs, specific functions for ANKRD65-AS1 uncharacterized)

Disease associations

Not established for ANKRD65-AS1 specifically. In general, dysregulated antisense lncRNAs are increasingly implicated in cancer, imprinting disorders, and neurodegenerative diseases, but no direct disease association is confirmed for this gene.

Beyond the preview

Go deeper on ANKRD65 antisense RNA 1 (ANKRD65-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ANKRD65 antisense RNA 1 (ANKRD65-AS1).

Explore the full profile